日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tilapia Skin in Burn Injuries: A Narrative Review of Pathophysiology, Current Management, and Therapeutic Applications

罗非鱼皮在烧伤中的应用:病理生理学、当前管理和治疗应用的叙述性综述

Szot, Mateusz; Zakrys, Mikolaj; Zakrys, Katarzyna; Stupnicki, Szymon; Oparcik, Aleksandra; Tarczykowski, Jakub; Kwasniewska, Natalia; Czaplinski, Mieszko

A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS Tumors

菲美匹诺司他治疗复发难治性实体瘤和中枢神经系统肿瘤儿童及青少年的I期临床试验

Shulman, David S; Vo, Kieuhoa T; Balis, Frank M; Lindsay, Holly; Bagatell, Rochelle; Place, Andrew E; Chi, Susan N; Shusterman, Suzanne; Ezrre, Suzanne; Czaplinski, Jeffrey; Bhushan, Ketki; Kao, Pei-Chi; London, Wendy B; DuBois, Steven G

Formation and Stability of the Propionitrile:Acetylene Co-Crystal Under Titan-Relevant Conditions

钛相关条件下丙腈:乙炔共晶的形成与稳定性

Czaplinski, Ellen C; Vu, Tuan H; Maynard-Casely, Helen; Ennis, Courtney; Cable, Morgan L; Malaska, Michael J; Hodyss, Robert

Axonal mRNA binding of hnRNP A/B is crucial for axon targeting and maturation of olfactory sensory neurons

hnRNP A/B 的轴突 mRNA 结合对于嗅觉传感神经元的轴突靶向和成熟至关重要

Nanaho Fukuda, Tomoyuki Fukuda, Piergiorgio Percipalle, Kanako Oda, Nobuyuki Takei, Kevin Czaplinski, Kazushige Touhara, Yoshihiro Yoshihara, Toshikuni Sasaoka

Experimental Characterization of the Pyridine:Acetylene Co-crystal and Implications for Titan's Surface

吡啶:乙炔共晶体的实验表征及其对土卫六表面的意义

Czaplinski, Ellen C; Vu, Tuan H; Cable, Morgan L; Choukroun, Mathieu; Malaska, Michael J; Hodyss, Robert

Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis

复发型多发性硬化症患者长期皮下注射奥法妥木单抗的耐受性

Kramer, John; Linker, Ralf; Paling, David; Czaplinski, Adam; Hoffmann, Olaf; Yong, V Wee; Barker, Noreen; Ross, Amy Perrin; Lucassen, Elisabeth; Gufran, Mohammad; Hu, Xixi; Zielman, Ronald; Seifer, Gustavo; Vermersch, Patrick

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

多发性硬化症治疗共识小组(MSTCG):关于多发性硬化症疾病修饰疗法的立场声明(白皮书)

Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; Gobbi, Claudio; Goebels, Norbert; Guger, Michael; Haghikia, Aiden; Hartung, Hans-Peter; Heidenreich, Fedor; Hoffmann, Olaf; Kallmann, Boris; Kleinschnitz, Christoph; Klotz, Luisa; Leussink, Verena I; Leutmezer, Fritz; Limmroth, Volker; Lünemann, Jan D; Lutterotti, Andreas; Meuth, Sven G; Meyding-Lamadé, Uta; Platten, Michael; Rieckmann, Peter; Schmidt, Stephan; Tumani, Hayrettin; Weber, Frank; Weber, Martin S; Zettl, Uwe K; Ziemssen, Tjalf; Zipp, Frauke

[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]

[多发性硬化症治疗共识小组(MSTCG):2021年多发性硬化症疾病修饰治疗立场文件(白皮书)]

Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Stangel, Martin; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; Gobbi, Claudio; Goebels, Norbert; Guger, Michael; Haghikia, Aiden; Hartung, Hans-Peter; Heidenreich, Fedor; Hoffmann, Olaf; Hunter, Zoë R; Kallmann, Boris; Kleinschnitz, Christoph; Klotz, Luisa; Leussink, Verena; Leutmezer, Fritz; Limmroth, Volker; Lünemann, Jan D; Lutterotti, Andreas; Meuth, Sven G; Meyding-Lamadé, Uta; Platten, Michael; Rieckmann, Peter; Schmidt, Stephan; Tumani, Hayrettin; Weber, Martin S; Weber, Frank; Zettl, Uwe K; Ziemssen, Tjalf; Zipp, Frauke

SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting

SwissTecLive:富马酸二甲酯在瑞士临床实践中治疗复发缓解型多发性硬化症的有效性和安全性

Zecca, Chiara; Czaplinski, Adam; Henny, Christophe; Petrini, Liliane; Beeler, Andreas; Gobbi, Claudio

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

更正:酪氨酸激酶抑制剂对伊马替尼耐药性胃肠道间质瘤中继发性kit突变的互补活性

Serrano, César; Mariño-Enríquez, Adrián; Tao, Derrick L; Ketzer, Julia; Eilers, Grant; Zhu, Meijun; Yu, Channing; Mannan, Aristotle M; Rubin, Brian P; Demetri, George D; Raut, Chandrajit P; Presnell, Ajia; McKinley, Arin; Heinrich, Michael C; Czaplinski, Jeffrey T; Sicinska, Ewa; Bauer, Sebastian; George, Suzanne; Fletcher, Jonathan A